REMEDI - Medicine - The Regenerative Medicine Institute - Research
REMEDI offers both MSc and PhD degrees within our research areas as described below. Admission to a research degree is at the discretion of the potential supervisor, the Head of Department and the College of Medicine, Nursing, and Health Sciences and is based on a proposal by the applicant following discussion with the member of academic staff who research area is most appropriate. Applicants should hold an honours degree (Second Class Honours, minimum). Specialisation at undergraduate level in an area relevant to the proposed research is highly desirable.
The Regenerative Medicine Institute (REMEDI) is a world-class biomedical research centre focusing on gene therapy and stem cell research. In state-of-the-art facilities, researchers at REMEDI work together to combine the technologies of gene therapy and adult stem cell therapy with the aim of regeneration and repair of tissues. The unique feature of the research carried out at REMEDI is the novel integration of both therapies in a complementary research and development programme.
REMEDI researchers have established expertise in gene therapy, stem cell biology, biomaterial science, immunology and medical devise technologies, all essential elements of minimally invasive approaches to regenerative medicine. Research programmes are in place to develop novel therapies for cardiovascular, athritis/orthopaedic and neural applications aspect of its research programmes towards the clinic.
PhD candidates should normally have a high honours standard in a relevant academic discipline at primary degree level or equivalent together with the support of an academic staff member who is approved by the College to supervise the research in terms of its nature and scope.
Additional entry requirements
Candidates may be required to submit a research proposal for consideration by the School as part of their application.
Applications are made online via the NUI Galway Postgraduate Applications System.
PhD (part-time) 1PM2
PhD (REMEDI), part-time
Stem Cell Science
Biomaterials for Novel Biotherapeutics